Amaç: Epilepsi nörofi bromatozisli hastaların yaklaşık %4-7’sinde görülür. Bu oran genel popülasyon için yayınlanan %1-2’den yüksektir. Çalışmamızın amacı, NF1 ve epilepsili hastaların sonuçları ve klinik karakteristiklerini tanımlamaktır.Gereç ve Yöntemler: Bu çalışma için üçüncü basamak merkezimizde Ocak 2000 ve Şubat 2010 tarihleri arasında takip edilen 35 hasta değerlendirildi. Her hastaya elektrofi zyolojik ve nöroradyolojik inceleme yapıldı.Bulgular: NF1’li hastaların %34.2’sinde en az bir nöbet, %17.1’inde epilepsi öyküsü vardı. Jeneralize nöbetlerde görülmesine rağmen, fokal nöbetler hastaların %66’sında meydana gelen en sık nöbet tipiydi. Epilepsi 2 hastada serebral hamartomla, 3 hastada tanımlanamayan parlak objeler şeklinde beyin lezyonları ile görüldü. Nöbetler 3 hastada (%50) tek antiepileptik, 3 hastada (%50) multiple antiepileptik ile kontrol edildi.Sonuç: Bizim gözlemlerimiz ve bizim bulgularımızla literatürün tekrar incelenmesi bize NF1’li hastalarda intrakranial lezyonla ilişkili epilepsi riski olduğunu gösterdi. Nöbetler kortikal lezyonların ya da bir tümörün ilk semptomu olabilir. Biz nöbeti olan NF1’li hastalarda hastaların radyolojik takibinin göz önünde bulundurulması gerektiğini düşünüyoruz.
Objective: Epilepsy occurs in approximately 4-7% of individuals with Neurofi bromatosis type 1 (NF1). This is higher than the 1-2% value reported for the general population. The aim of the study was to describe the clinical characteristics and outcomes of individuals with NF1 and epilepsy.Material and Methods: This study evaluated 35 patients who were followed up for NF1 at our tertiary care center between January 2000 and February 2010. Every patient underwent electroencephalographic examination and neuroimaging investigations.Results: A history of at least one unprovoked seizure was present in 34.2% of NF1 patients and 17.1% had documented epilepsy. Focal seizures were the most common type, occurring in 57% of individuals, although generalized seizures were also noted. Epilepsy presented with brain lesions such as cerebral hamartoma in two patients and unidentifi ed bright objects in three patients. Seizures were controlled with a single antiepileptic drug in three (50%) and multiple antiepileptic drugs in three (50%) patients.Conclusion: Our observations and our re-evaluation of the literature indicate that patients with neurofi bromatosis 1 have an increased risk of epilepsy related to intracranial lesions and seizures can represent the fi rst symptom of a tumor or cortical lesions. We conclude that radiological follow-up should be considered in NF1 patients with seizures
Other ID | JA73CV36PR |
---|---|
Journal Section | Research Article |
Authors | |
Publication Date | June 1, 2014 |
Submission Date | June 1, 2014 |
Published in Issue | Year 2014 Volume: 8 Issue: 3 |
The publication language of Turkish Journal of Pediatric Disease is English.
Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.
The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.